RankingsPricing
  1. US-listed companies
  2. Amphastar Pharmaceuticals, Inc.
  3. Financials
  4. FCF margin (%)

Amphastar Pharmaceuticals, Inc.AMPH

Market cap
$1.2B
P/E ratio
SummaryFinancials
Period EndFCF margin (%) YoY (%)
Dec 31, 202423.5+4.40%
Dec 31, 202322.6+72.75%
Dec 31, 202213.1-18.97%
Dec 31, 202116.1+140.79%
Dec 31, 20206.7+10321.01%
Dec 31, 20190.1-102.20%
Dec 31, 2018-2.9-270.89%
Dec 31, 20171.7-74.58%
Dec 31, 20166.7-553.11%
Dec 31, 2015-1.5-231.33%
Dec 31, 20141.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)